Letter to CMS - Payment Models for CAR-T Cell Therapy

By User Admin posted 09-15-2017 00:00

  

Recent Advocacy Activity from the ASBMT 


This month, the ASBMT sent three letters of importance to the Centers for Medicare & Medicaid Services. 

Below are links to the letters.  

ASBMT Commentary on CY2018 Proposed Changes to Physician Fee Schedule
CMS Payment Models for Chimeric Antigen Receptor T Cell (CAR-T) Therapy
ASBMT Concerns with Proposed Changes to Outpatient Reimbursement Policies  

0 comments
9 views

Permalink